NSE - Delayed Quote INR

Krebs Biochemicals & Industries Limited (KREBSBIO.NS)

78.41

-3.42

(-4.18%)

At close: 3:29:13 PM GMT+5:30

Alphabet earnings & antitrust, Tesla surges: Trending Tickers

Julie Hyman and TheBigSkinny.com founder and Prairie Operating Company executive vice president of market strategy Lou Basenese take a closer look at some of today's trending tickers. Google's parent company, Alphabet (GOOG, GOOGL), is in focus after releasing first quarter earnings that beat on the top and bottom lines and announcing a dividend boost along with $70 billion in buybacks. The Department of Transportation announces new self-driving car rules, sending Tesla (TSLA) stock surging. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.

Yahoo Finance Video 22 minutes ago

GOOG

TSLA
Tesla in India, Saia Q1 miss, SoFi initiated by Citizens JMP

Julie Hyman goes over some of the trading day's top stories on this segment of Market Minute. Tesla (TSLA) stock jumps as the company refunded early Model 3 bookings in India, according to Bloomberg. The move raises speculation that Tesla is nearing an entry point into India. Saia (SAIA) stock slides after missing first quarter earnings and revenue targets, citing tough weather and macro headwinds. SoFi Technologies (SOFI) stock is rising after Citizens JMP initiated coverage on the stock with an Outperform rating and $17 price target. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.

Yahoo Finance Video 2 hours ago

TSLA

SOFI

SAIA
Commentary: DOGE gets downsized

Congress is trying to formalize a small amount of the federal spending cuts Elon Musk's government efficiency project has claimed. It won't be easy.

Yahoo Finance 3 hours ago

TSLA
Phillips 66, Boston Beer, Charter Communications: Trending Tickers

With the trading session underway, Catalysts host Madison Mills and Yahoo Finance Markets Reporter Josh Schafer examine some of today's trending tickers. Phillips 66 (PSX) announces a wider-than-expected first quarter loss amid pressure from activist investors. Boston Beer Company's (SAM) first quarter earnings results beat expectations, but the company warned of a tariff impact of up to $30 million in 2025. Charter Communications's (CHTR) first quarter sales came in better than expected, with customer losses narrowing year over year. To watch more expert insights and analysis on the latest market action, check out more Catalysts here.

Yahoo Finance Video 5 hours ago

SAM

PSX

CHTR
Verizon, AT&T, and T-Mobile prepare to raise prices on consumers because of Trump's trade war

America's biggest phone carriers warn about much higher prices if tariffs on smartphones were to kick in.

Yahoo Finance 8 hours ago

T

T-P-A

AAPL
Skechers, Boyd Gaming, T-Mobile: Trending Tickers

Julie Hyman takes a look at some of the trending tickers in extended-hours trading. Skechers (SKX) stock sinks after the company withdrew its guidance and reported an earnings miss. Boyd Gaming (BYD) stock pops after the company's earnings and revenue results topped analyst estimates. T-Mobile (TMUS) stock falls after announcing softer-than-expected phone customer numbers. To watch more expert insights and analysis on the latest market action, check out more Asking for a Trend here.

Yahoo Finance Video 22 hours ago

BYD

TMUS

SKX
BigBear.ai Shares Jump 11% on Friday After Announcing AI Deal With Austal USA

Shipyard AI will support Austal USA's modernization at its Mobile, Alabama, facility.

GuruFocus.com 9 minutes ago

ASB.AX

BBAI-WS
Saia’s shares sag 30% as tariffs tank demand, exacerbate growing pains

Saia’s shares are getting punished as the company’s ambitious growth efforts have been derailed by a trade war. The post Saia’s shares sag 30% as tariffs tank demand, exacerbate growing pains appeared first on FreightWaves.

FreightWaves 17 minutes ago

SAIA
AbbVie Hikes Its Outlook On The Back Of Two Powerhouse Drugs

AbbVie stock inched higher Friday after the pharma titan hiked its outlook on the back of strength from its immunology powerhouses.

Investor's Business Daily 23 minutes ago

ABBV
Sector Update: Health Care Stocks Advance Late Afternoon

Health care stocks were higher late Friday afternoon, with the NYSE Health Care Index up 0.3% and th

PREMIUM
MT Newswires 26 minutes ago

ABBV
Is Tesla Stock A Buy Or A Sell With Elon Musk Stepping Back From The Trump White House?

Tesla stock is down this year but investors appear to be regaining confidence following Elon Musk's Q1 earnings call performance.

Investor's Business Daily 26 minutes ago

TSLA
Sector Update: Consumer Stocks Mixed Late Afternoon

Consumer stocks were mixed late Friday afternoon with the Consumer Staples Select Sector SPDR Fund (

PREMIUM
MT Newswires 33 minutes ago

SPOT
Why Reddit Stock Jumped This Week

Shares of Reddit (NYSE: RDDT) were moving higher this week, even though there was no news out on the social media stock. Instead, the company seemed to benefit from the broader rebound in the stock market, driven by cooling trade tensions, and gained on Friday in sympathy with a better-than-expected earnings report from Google parent Alphabet. Investors also appeared to take advantage of the company's beaten-down stock price, as Reddit shares had fallen sharply in recent months on broader signs of economic weakness.

Motley Fool 45 minutes ago

RDDT
Nvidia Stock Jumped Another 5% Today. Does It Have More Room to Run?

Tariffs, trade policy, and the risk of recession have all contributed to market turmoil lately. Shares in tech giant Nvidia (NASDAQ: NVDA) have been rebounding sharply in recent days after a more than 20% drop over the last month. Nvidia shares dropped to as low as $95 in early April, but have rebounded to near $110 per share as this week's trading nears a close.

Motley Fool 45 minutes ago

NVDA
Stock Market Today: Nasdaq Jumps, Dow Jones Flat, But Weekly Gains In Sight; Apple Makes Huge Plan Amid Trump Tariff Threat

Major stock indexes held firm in the stock market today after three days of bullish gains. Tesla spiked 9% and Nvidia led the Dow.

Investor's Business Daily 1 hour ago

GOOG

AAPL

NVDA
FDA Asks Vaccine Maker to Complete New Clinical Trial for Delayed Covid-19 Shot

Federal regulators are asking Novavax to complete an additional randomized clinical trial on its Covid-19 vaccine after previously delaying approval, people familiar with the matter said, a request that could be so prohibitively expensive the company might not be able to fulfill it. The Maryland-based company was asked by the Food and Drug Administration to show its vaccine is effective with another randomized study after appointees under Health Secretary Robert F. Kennedy Jr. intervened in the approval process, the people said. A new randomized trial with enough participants to judge the vaccine’s ability to prevent disease could cost tens of millions of dollars, vaccine experts said.

The Wall Street Journal 1 hour ago

NVAX
Why a Cautious, Longtime Investor Is Rather Bullish on NVDA

Harvest Portfolio Management Chief Investment Officer Paul Meeks is cautious on the Mag 7 overall, suggesting that investors not buy any of the names until after they report their first-quarter earnings. Moreover, he does not believe that any of the companies will have much confidence in their outlooks, and he does not expect AI to […]

Insider Monkey 1 hour ago

NVDA
Interim Overall Survival Analysis Requested from Chinese Health Authorities Shows a Clinically Meaningful, Positive Trend Favoring Ivonescimab Compared to Pembrolizumab in PD-L1 Positive Advanced NSCLC from HARMONi-2 Study Conducted by Akeso in China

MIAMI, April 25, 2025--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today noted that Akeso, Inc. (Akeso, HKEX Code: 9926.HK) announced that ivonescimab was approved by the Chinese Health Authorities, the National Medical Products Administration (NMPA), for a second indication based on the results of the Phase III clinical trial, HARMONi-2 or AK112-303. HARMONi-2 evaluated monotherapy ivonescimab against monotherapy pembrolizumab in patients with locally advanced or

Business Wire 1 hour ago

SMMT
Why Nvidia Stock Is Rising Today

Shares of Nvidia (NASDAQ: NVDA) are surging higher on Friday. This comes as the S&P 500 was up 0.4% and Nasdaq Composite was up 1%. Shares of the chipmaker were lifted after Morgan Stanley raised its revenue projections for the company as well as the revelation of some positive news in the ongoing trade war with China.

Motley Fool 1 hour ago

NVDA
Market Chatter: Spotify Technology to Increase Subscription Prices in Europe, Latin America

Spotify Technology (SPOT) will increase subscription prices by 1 Euro ($1.14) on individual subscrip

PREMIUM
MT Newswires 1 hour ago

SPOT

Performance Overview

Return	KREBSBIO.NS	S&P BSE SENSEX (^BSESN)
YTD	-15.68%	+1.37%
1-Year	+9.59%	+6.56%
3-Year	-51.88%	+40.00%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Krebs Biochemicals & Industries Limited (KREBSBIO.NS)

Related News

Alphabet earnings & antitrust, Tesla surges: Trending Tickers

Tesla in India, Saia Q1 miss, SoFi initiated by Citizens JMP

Commentary: DOGE gets downsized

Phillips 66, Boston Beer, Charter Communications: Trending Tickers

Verizon, AT&T, and T-Mobile prepare to raise prices on consumers because of Trump's trade war

Skechers, Boyd Gaming, T-Mobile: Trending Tickers

BigBear.ai Shares Jump 11% on Friday After Announcing AI Deal With Austal USA

Saia’s shares sag 30% as tariffs tank demand, exacerbate growing pains

AbbVie Hikes Its Outlook On The Back Of Two Powerhouse Drugs

Sector Update: Health Care Stocks Advance Late Afternoon

Is Tesla Stock A Buy Or A Sell With Elon Musk Stepping Back From The Trump White House?

Sector Update: Consumer Stocks Mixed Late Afternoon

Why Reddit Stock Jumped This Week

Nvidia Stock Jumped Another 5% Today. Does It Have More Room to Run?

Stock Market Today: Nasdaq Jumps, Dow Jones Flat, But Weekly Gains In Sight; Apple Makes Huge Plan Amid Trump Tariff Threat

FDA Asks Vaccine Maker to Complete New Clinical Trial for Delayed Covid-19 Shot

Why a Cautious, Longtime Investor Is Rather Bullish on NVDA

Interim Overall Survival Analysis Requested from Chinese Health Authorities Shows a Clinically Meaningful, Positive Trend Favoring Ivonescimab Compared to Pembrolizumab in PD-L1 Positive Advanced NSCLC from HARMONi-2 Study Conducted by Akeso in China

Why Nvidia Stock Is Rising Today

Market Chatter: Spotify Technology to Increase Subscription Prices in Europe, Latin America

Performance Overview